Core Laboratories (CLB) closed at $10.64 on October 30, 2026, up 2.3% from the previous close, on volume of 812,141 shares (30-day average 674,464).
Data as of October 30, 2026.
30-Oct-2026
Core Laboratories Earnings Call Balances Progress And Risk
TipRanks (Thu, 29-Oct 8:06 PM ET)
Core Laboratories declares $0.01 dividend
Seeking Alpha News (Thu, 29-Oct 3:26 AM ET)
CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:
PRNewswire (Wed, 28-Oct 5:16 PM ET)
Core Laboratories Posts Solid Q3 2026 Revenue Growth
TipRanks (Wed, 28-Oct 4:56 PM ET)
Core Laboratories GAAP EPS of $0.12 misses by $0.03, revenue of $132.1M in-line
Seeking Alpha News (Wed, 28-Oct 4:56 PM ET)
Here are the major earnings after the close Wednesday
Seeking Alpha News (Wed, 28-Oct 10:00 AM ET)
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
PRNewswire (Thu, 1-Oct 4:15 PM ET)
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
Core Laboratories trades on the NYSE stock market under the symbol CLB.
As of October 30, 2026, CLB stock price climbed to $10.64 with 812,141 million shares trading.
CLB has a beta of 0.77, meaning it tends to be less sensitive to market movements. CLB has a correlation of 0.03 to the broad based SPY ETF.
CLB has a market cap of $488.21 million. This is considered a Small Cap stock.
Last quarter Core Laboratories reported $132 million in Revenue and $.16 earnings per share. This beat revenue expectation by $167,112 and met earnings estimates .
In the last 3 years, CLB traded as high as $25.13 and as low as $9.13.
The top ETF exchange traded funds that CLB belongs to (by Net Assets): IWM, VTI, DFAT, VXF, IWN.
CLB has underperformed the market in the last year with a return of -33.7%, while SPY returned +11.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CLB shares. However, CLB has outperformed the market in the last 3 month and 2 week periods, returning +7.9% and +8.8%, while SPY returned +3.9% and -2.1%, respectively. This indicates CLB has been having a stronger performance recently.
CLB support price is $10.10 and resistance is $10.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLB shares will trade within this expected range on the day.